Experiments for taxon Citrus paradisi (RUTACEAE)

Experiments (580 results)

Filters
Worktypes (48)
147
116
62
57
49
46
44
43
42
39
38
38
32
29
27
25
24
19
11
9
8
7
7
6
6
6
5
5
5
4
4
4
3
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
No match
Pharmacology (91)
121
38
36
27
23
18
8
7
6
6
5
5
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
183
No match
Compounds (206)
34
30
15
10
8
8
8
7
6
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
367
No match
Organisms (300)
25
16
12
11
10
9
9
8
7
7
7
7
6
6
6
6
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
17 rarer values not listed
580 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
646370
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
538190
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIOXIDANT ACTIVITY
Citrus paradisi (RUTACEAE)
67031
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
968816
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTATHIONE-S-TRANSFERASE INDUCTION
Citrus paradisi (RUTACEAE)
67725
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
67336
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1141226
PHARMACOLOGY OF EXTRACT - IN VIVO
ACTH-INDUCTION
Citrus paradisi (RUTACEAE)
67549
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
68693
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1301308
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
LIPOLYTIC EFFECT
Citrus paradisi (RUTACEAE)
728145
MEDICINAL FOLKLORE REPORTED FOR
ANTIDIARRHEAL ACTIVITY
Citrus paradisi (RUTACEAE)
625221
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NARINGIN
1132973
BIOSYNTHESISQUANTITATIVE DATAISOLATION FROM DURING BIOSYNTHESIS STUDY
Citrus paradisi (RUTACEAE)
LIMONOATE A-RING LACTONE
610724
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
239135
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BENZOPYRAN-7-ONE,4-[[6-HYDROXY-7-[[4-METHYL-1-(1-METHYL-ETHENYL)-6-(7-OXO-7(H)-FUROL[3-2-G][1]-BENZOPYRAN-4-YL)-4-HEXENYL]-OXY]-3-7-DIMETHYL-2-OCTENYL]-OXY]-7(H)-FUROL[3-2-G]-[1]
684544
PHARMACOLOGY OF COMPOUND - IN VITRO
MISCELLANEOUS EFFECTS
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7'-DIHYDROXY:
1284301
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
276559
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
CITRACRIDONE I
1283871
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
CARDIOTOXIC ACTIVITY
Citrus paradisi (RUTACEAE)
778309
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
778304
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
GALLIC ACID
66975
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTATHIONE FORMATION INHIBITION
Citrus paradisi (RUTACEAE)
374461
PHARMACOLOGY OF EXTRACT - IN VITRO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
620860
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
651442
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERCHOLESTEROLEMIC ACTIVITY
Citrus paradisi (RUTACEAE)
69060
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1308610
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 3A4 INHIBITION
Citrus paradisi (RUTACEAE)
COUMARIN,7-GERANYL-OXY:MARMINMARMIN-6′,7′-DECANAL-ACETAL:
103848
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
OBACUNOIC ACID,17-O-BETA-D-GLUCOSIDE
66976
PHARMACOLOGY OF EXTRACT - IN VIVO
CATALASE INHIBITION
Citrus paradisi (RUTACEAE)
66815
PHARMACOLOGY OF EXTRACT - IN HUMANS
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
511742
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
450731
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
NARIRUTINNARIRUTIN-GLUCOSIDE
368834
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
684537
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Citrus paradisi (RUTACEAE)
804835
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
368849
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
152310
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
AZACRIDONE A
399128
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
602888
QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS
Citrus paradisi (RUTACEAE)
SYNEPHRINE
368850
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
404692
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1284683
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
971102
IDENTIFICATION IN BY GLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
CYMENE,PARA:LIMONENELINALOOLTERPINEN-4-OL
675558
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
1245385
PHARMACOLOGY OF EXTRACT - IN VITROQUANTITATIVE PHARMACOLOGICAL DATA REPORTED FOR CRUDE EXTRACT
ANTIMYCOBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
646755
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Citrus paradisi (RUTACEAE)
69089
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
653382
PHARMACOLOGY OF COMPOUND - IN VITRO
TESTOSTERONE HYDROXYLASE INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
715833
PHARMACOLOGY OF EXTRACT - IN HUMANS
CYTOCHROME P450 INDUCTION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7'-DIHYDROXY:
637335
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
596502
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
276555
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
GRANDISININE
270693
PHARMACOLOGY OF EXTRACT - IN VIVO
ALANINE AMINOTRANSFERASE INHIBITION
Citrus paradisi (RUTACEAE)
684548
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAPTEN
1198022
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
68588
PHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
397677
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIPLATELET ACTIVITY
Citrus paradisi (RUTACEAE)
352135
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
68116
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Citrus paradisi (RUTACEAE)
1308608
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
363764
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NARINGIN
537314
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
APIGENIN-7-(2-O-ALPHA-RHAMNOSYL-BETA-D-GLUCOSIDE)PRUNIN
179836
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
MARSHMINE
554258
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Citrus paradisi (RUTACEAE)
452758
PHARMACOLOGY OF EXTRACT - IN HUMANS
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
399483
PHARMACOLOGY OF EXTRACT - IN HUMANS
METABOLISM INHIBITION
Citrus paradisi (RUTACEAE)
380738
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
LUTEIN
68635
PHARMACOLOGY OF EXTRACT - IN HUMANS
Citrus paradisi (RUTACEAE)
646751
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Citrus paradisi (RUTACEAE)
719537
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTATHIONE-S-TRANSFERASE INDUCTION
Citrus paradisi (RUTACEAE)
688605
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
NARINGIN
890601
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPERKALEMIC ACTIVITY
Citrus paradisi (RUTACEAE)
450735
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
NARINGIN
653383
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
1289981
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Citrus paradisi (RUTACEAE)
955519
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Citrus paradisi (RUTACEAE)
LIMONINNOMILIN
368838
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
68115
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIOXIDANT ACTIVITY
Citrus paradisi (RUTACEAE)
800424
MEDICINAL FOLKLORE REPORTED FOR
ANTIMALARIAL ACTIVITY
Citrus paradisi (RUTACEAE)
1308603
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
MARMIN-6′,7′-DECANAL-ACETAL:
370860
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
410242
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
NARINGINNARINGENIN RUTINOSIDE
684550
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAPTOL
642925
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
368853
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
371054
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1292472
PHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
621874
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
368844
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
625216
PHARMACOLOGY OF EXTRACT - IN VITRO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
901509
PHARMACOLOGY OF EXTRACT - IN HUMANS
RBC ANTIADHESANT
Citrus paradisi (RUTACEAE)
1096946
IDENTIFICATION IN BY RIAQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
NARINGIN
68350
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
1105434
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPLETE SYNTHESIS REPORTED
Citrus paradisi (RUTACEAE)
NAPHTHOQUINONE,1-4: PERHYDRO: 3(S)-ISO-PROPENYL-4-ALPHA-(S)-5(R)-DIMETHYL: (8-ALPHA-(S): (+):NAPHTHALENONE,2(1H): 4-ALPHA-(R)-5-6-(R)-7-8-8:ALPHA-(S)-HEXAHYDRO: 6-ISO-PROPLENYL-4-8-ALPHA-DIMETHYL:NAPHTHALENONE,2(1H): 4-ALPHA-(R)-5-6-(R)-7-8-8-ALPHA-(R)-HEXAHYDRO: 6-ISO-PROPENYL-4-8-ALPHA-DIMETHYL: (+):NAPHTHALENONE,2(1H): 4-ALPHA-(R)-5-6-7-8-8-ALPHA-(R)-HEXAHYDRO: 6-ISO-PROYL-DENE-4-8-ALPHA-DIMETHYL: (+):NAPHTHALENONE,2(1H): 4-ALPHA-(S)-5-6-(4)-7-8-8-ALPHA-(R)-HEXAHYDRO: 6-ISO-PROPENYL-4-8-ALPHA-DIMETHYL: (-):NAPHTHOQUINONE,1-4: 2-3-4-4(A)-5-6-HEXAHYDRO: 3(S)-ISO-PROPENYL-4-ALPHA-(S)-5-(R)-DIMETHYL: (+):
66814
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
806747
PHARMACOLOGY OF EXTRACT - IN VITRO
KETOSIS INHIBITION
Citrus paradisi (RUTACEAE)
576400
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
715836
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
PARADISIN A
647134
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
201828
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
MARGRAPINE B
41739
CHEMOTAXONOMY MARKER CODEISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NOMILIN,DEACETYL:LIMONINOBACUNONE
368833
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
554259
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
66968
CLINICAL STUDIES
PLATELET AGGREGATION INHIBITION
Citrus paradisi (RUTACEAE)
1276781
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
276562
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
XANTHYLETIN
554507
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Citrus paradisi (RUTACEAE)
397016
PHARMACOLOGY OF EXTRACT - IN VIVO
TUMOR INITIATION INHIBITION
Citrus paradisi (RUTACEAE)
626233
PHARMACOLOGY OF COMPOUND - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7'-DIHYDROXY:NARINGIN
68112
PHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
1308607
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
COUMARIN,7-GERANYL-OXY:
583568
MEDICINAL FOLKLORE REPORTED FOR
DIGESTANT ACTION
Citrus paradisi (RUTACEAE)
388593
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Citrus paradisi (RUTACEAE)
636697
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
UMBELLIFERONE
623665
PHARMACOLOGY OF EXTRACT - IN VITRO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
653385
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
1254590
PHARMACOLOGY OF EXTRACT - IN VIVOCARCINOGENIC DATA (MARKER CODE)TOXICITY MARKER CODEREVIEW OF
CARCINOGENIC ACTIVITY
Citrus paradisi (RUTACEAE)
1112888
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
68187
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
591470
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1119406
PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANTIHYPERTENSIVE ACTIVITY
Citrus paradisi (RUTACEAE)
FLAVONE,4'-5-7-TRIHYDROXY: 6-C-GLUCOSIDEFLAVONE,4'-5-6-7-TETRAHYDROXY: 8-O-BETA-D-DIGLUCOSIDE
207858
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
BISOSTHENON B
378349
PHARMACOLOGY OF COMPOUND - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
NARINGIN
393682
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
368855
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
931151
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Citrus paradisi (RUTACEAE)
1308611
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 3A4 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6′,7′-DIHYDROXY-DECANAL-ACETAL:BERGAMOTTIN,6′,7′-DIHYDROXY-OCTANAL-ACETAL:BERGAMOTTINBERGAMOTTIN,6'-7'-DIHYDROXY:
783797
PHARMACOLOGY OF EXTRACT - IN VIVO
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
67742
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
450732
IDENTIFICATION IN BY HPLC
Citrus paradisi (RUTACEAE)
RHOIFOLIN,ISO:HESPERIDINERIOCITRINRHOIFOLINERIOCITRIN,ISO:SAKURANETIN,ISO:DIOSMINNARINGIN-6''-MALONATEHESPERIDIN,NEO:NARINGINNARINGIN GLUCOSIDE
1093560
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
OBACUNOL,7-ALPHA:
1299363
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANALGESIC ACTIVITY
Citrus paradisi (RUTACEAE)
757233
PHARMACOLOGY OF EXTRACT - IN VITRO
LARVICIDAL ACTIVITY
Citrus paradisi (RUTACEAE)
207857
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
MARSHDIMERIN
457790
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
878446
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
HESPERIDINNARIRUTINHESPERIDIN,NEO:NARINGIN
67426
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
194349
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
CITBISMINE D
67396
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
621682
PHARMACOLOGY OF EXTRACT - IN VIVO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
368842
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
229582
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
NEOACRIMARINE J
671902
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
630342
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIADHESION EFFECT
Citrus paradisi (RUTACEAE)
1289966
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Citrus paradisi (RUTACEAE)
67550
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
388594
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
67029
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
572697
VOUCHER SPECIMEN REPORTED FOR
Citrus paradisi (RUTACEAE)
625222
PHARMACOLOGY OF COMPOUND - IN VITRO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
NARINGIN
770594
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
1093561
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
LIMONOL
399129
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
554282
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
1112887
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
103849
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
OBACUNOIC ACID,TRANS: 17-O-BETA-D-GLUCOSIDE
524185
PHARMACOLOGY OF EXTRACT - IN VIVO
METABOLISM INHIBITION
Citrus paradisi (RUTACEAE)
370866
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
450736
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
HESPERIDINERIOCITRINHESPERIDIN,NEO:NARINGIN
395739
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1198019
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
684542
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7'-DIHYDROXY:
229583
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
NEOACRIMARINE K
671598
PHARMACOLOGY OF EXTRACT - IN VIVO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
675556
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
648597
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1198023
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
1119408
PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANTIHYPERTENSIVE ACTIVITY
Citrus paradisi (RUTACEAE)
FLAVANONE,5-HYDROXY-4'-METHOXY: 7-O-BETA-D-RHAMNOSYL-GLUCOSIDEFLAVONONE,4'-5-DIHYDROXY: 7-O-BETA-D-RHAMNOSYL-GLUCOSIDE
675557
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
178325
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
CITBISMINE A
69473
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
1141225
PHARMACOLOGY OF EXTRACT - IN VIVO
ALDOSTERONE AGONIST ACTIVITY
Citrus paradisi (RUTACEAE)
637339
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
980300
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NOMILIN
67312
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
54928
PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
LIMONOATE A-RING LACTONE
546202
PHARMACOLOGY OF EXTRACT - IN HUMANS
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
1085844
IDENTIFICATION IN BY GLCQUANTITATIVE DATA REPORTEDCHEMOTAXONOMY MARKER CODE
Citrus paradisi (RUTACEAE)
SUBEROSINPONCITRINXANTHOXYLETINBRAYLINSESELINPYRANOCOUMARIN,GERANYL-OXY:OSTHOLXANTHYLETIN
1063917
PRESENT IN (REVIEW)
Citrus paradisi (RUTACEAE)
FRIEDELIN
368848
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
67454
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
1303874
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
393679
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
370401
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
546203
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1274011
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
DIPHENYL AMINE
783798
PHARMACOLOGY OF EXTRACT - IN VIVO
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
276564
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
CITFLAVANONE
684549
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
BERGAPTOL
772521
PHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
589461
IDENTIFICATION IN BY GLCQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
DIPHENYLAMINE
67308
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1308609
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7'-DIHYDROXY:
68664
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
617154
ISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE
Citrus paradisi (RUTACEAE)
CYCLASE,CHALCONE:
68117
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIACNE ACTIVITY
Citrus paradisi (RUTACEAE)
67705
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
759120
PHARMACOLOGY OF EXTRACT - IN VIVO
DRUG ADDICTION
Citrus paradisi (RUTACEAE)
625215
PHARMACOLOGY OF EXTRACT - IN VITRO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
684538
PHARMACOLOGY OF EXTRACT - IN VITRO
MISCELLANEOUS EFFECTS
Citrus paradisi (RUTACEAE)
439081
VOUCHER SPECIMEN REPORTED FOR
Citrus paradisi (RUTACEAE)
397676
PHARMACOLOGY OF EXTRACT - IN VIVO
PLATELET AGGREGATION INHIBITION
Citrus paradisi (RUTACEAE)
646750
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Citrus paradisi (RUTACEAE)
380737
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
CRYPTOXANTHIN
715832
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7'-DIHYDROXY:
276556
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
CITPRESSINE I
596501
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
890602
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPONATREMIA ACTIVITY
Citrus paradisi (RUTACEAE)
368837
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
537313
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
APIGENIN-3-8-DI-C-GLUCOSIDELIMOCITRIN-3-O-[[5-ALPHA-GLUCOSYL-3-HYDROXY-3-METHYL-GLUTARYL(1-2)]-BETA-D-GLUCOSIDE]VICENIN 2
1202632
PHARMACOLOGY OF EXTRACT - IN VITRO
TUMOR PROMOTION INHIBITION
Citrus paradisi (RUTACEAE)
1283872
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
1099320
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
363688
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
326267
ION EXCHANGE METHODS USEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
PECTIN
67337
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
675552
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7-DIHYDROXY:
651443
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERCHOLESTEROLEMIC ACTIVITY
Citrus paradisi (RUTACEAE)
393676
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
647122
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
684545
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
1096945
IDENTIFICATION IN BY RIAQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
NARINGIN
1308606
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
MARMIN
621106
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
678953
QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS
Citrus paradisi (RUTACEAE)
LIMONENE
800423
VOUCHER SPECIMEN REPORTED FOR
Citrus paradisi (RUTACEAE)
806748
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
PONCIRINHESPERIDINQUERCETINNARINGIN,NEO:NARINGIN
370861
PHARMACOLOGY OF EXTRACT - IN HUMANS
HEMOGLOBIN INDUCTION
Citrus paradisi (RUTACEAE)
69235
REVIEW OF
Citrus paradisi (RUTACEAE)
751111
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NOOTKATONE
1286906
PHARMACOLOGY OF EXTRACT - IN VITRO
P-GLYCOPROTEIN TRANSPORT INHIBITION
Citrus paradisi (RUTACEAE)
636696
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
UMBELLIFERONE
201827
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
MARGRAPINE A
762021
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
621875
PHARMACOLOGY OF EXTRACT - IN VIVO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
367964
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
646754
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Citrus paradisi (RUTACEAE)
1184281
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
MERANZIN HYDRATEBENZDPYRAN-2-ONE,2-H-1: 8(3-BETA-D-GLUCOPYRANOSYL-OXY-2-HYDROXY-3-METHYL-BUTYL)-7-METHOXY:MERANZINMERANZIN,ISO:
625219
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NARINGENIN
69578
REVIEW OF
Citrus paradisi (RUTACEAE)
389385
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Citrus paradisi (RUTACEAE)
566899
PHARMACOLOGY OF EXTRACT - IN HUMANS
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
270694
PHARMACOLOGY OF EXTRACT - IN VIVO
ASPARTATE AMINOTRANSFERASE INHIBITION
Citrus paradisi (RUTACEAE)
516144
IDENTIFICATION IN BY HPLC
Citrus paradisi (RUTACEAE)
PRUNIN
523309
IDENTIFICATION IN BY GLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
DIPHENYLAMINE
538189
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Citrus paradisi (RUTACEAE)
346483
PHARMACOLOGY OF EXTRACT - IN HUMANS
HYDROXYSTEROID(11-BETA) DEHYDROGENASE INHIBITION
Citrus paradisi (RUTACEAE)
553066
MASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY GC/MS
Citrus paradisi (RUTACEAE)
AMYRIN,BETA:AMYRONE,BETA:AMYRIN,BETA: ACETATECYCLOARTANOL,24-METHYLENE:AMYRIN,ALPHA:AMYRIN,ALPHA: ACETATEFRIEDELINAMYRONE,ALPHA:
352220
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
363763
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
370863
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
531385
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
884763
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
HESPERIDINNARIRUTINHESPERIDIN,NEO:NARINGIN
362520
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
68025
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
778310
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NARINGIN
276553
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
ACRONYCINE,NOR: 5-HYDROXY: BIS:
626232
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NARINGIN
751113
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
AURAPTENE
276561
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
XANTHOXYLETIN
522434
MEDICINAL FOLKLORE REPORTED FOR
FOOD USE
Citrus paradisi (RUTACEAE)
804834
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
684539
PHARMACOLOGY OF EXTRACT - IN VITRO
MISCELLANEOUS EFFECTS
Citrus paradisi (RUTACEAE)
534093
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Citrus paradisi (RUTACEAE)
583569
MEDICINAL FOLKLORE REPORTED FOR
ANTIPYRETIC ACTIVITY
Citrus paradisi (RUTACEAE)
728146
MEDICINAL FOLKLORE REPORTED FOR
ANTIPYRETIC ACTIVITY
Citrus paradisi (RUTACEAE)
239131
PHARMACOLOGY OF EXTRACT - IN VITRO
TESTOSTERONE HYDROXYLASE INHIBITION
Citrus paradisi (RUTACEAE)
648598
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
554506
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
966388
PLANT TISSUE CULTURE MARKER CODEBIOSYNTHESISIDENTIFICATION IN BY HPLC
Citrus paradisi (RUTACEAE)
NOOTKATONEVALENCENE
1112882
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
394885
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
103845
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
NOMILINIC ACID,DEACETYL: 17-O-BETA-D-GLUCOSIDE
675555
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
488065
PHARMACOLOGY OF EXTRACT - IN HUMANS
FOOD-DRUG INTERACTION
Citrus paradisi (RUTACEAE)
54963
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Citrus paradisi (RUTACEAE)
SYNEPHRINE
68308
PHARMACOLOGY OF EXTRACT - IN HUMANS
METABOLISM OF
Citrus paradisi (RUTACEAE)
1101381
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Citrus paradisi (RUTACEAE)
67136
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1284302
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
66821
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1119405
UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
FLAVONE,4'-5-7-TRIHYDROXY: 6-C-GLUCOSIDEFLAVONE,4'-5-6-7-TETRAHYDROXY: 8-O-BETA-D-DIGLUCOSIDE
69061
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
BERGAMOTTINNARIRUTINBERGAMOTTIN,6'-7'-DIHYDROXY:NARINGIN
103844
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
NOMILINIC ACID-17-O-BETA-D-GLUCOSIDE
686802
PHARMACOLOGY OF EXTRACT - IN VITRO
GLYCOPROTEIN PROCESSING INHIBITION
Citrus paradisi (RUTACEAE)
1064137
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NOBILETINCOUMARIN,7-(3-7-DIMETHYL-6-EPOXY-OCT-TRANS-2-ENYL)-OXY):BERGAMOTTINBERGAPTOLCOUMARIN,7-METHOXY-8-(2-3-DIHYDROXY-ISO-PENTYL):MARMINCOUMARIN,7-GERANYL-OXY:TANGERETIN
715829
PHARMACOLOGY OF EXTRACT - IN HUMANS
CYTOCHROME P450 INDUCTION
Citrus paradisi (RUTACEAE)
112081
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
CITROPONE C
1198024
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
535615
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
778306
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
964991
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Citrus paradisi (RUTACEAE)
NARINGIN
778307
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
69472
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
689124
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE DISMUTASE STIMULATION
Citrus paradisi (RUTACEAE)
686801
PHARMACOLOGY OF EXTRACT - IN VITRO
GLYCOPROTEIN PROCESSING INHIBITION
Citrus paradisi (RUTACEAE)
103846
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
OBACUNOIC ACID,ISO: 17-O-BETA-D-GLUCOSIDE
253639
MASS-SPECTRAL FRAGMENTATION REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION OF A COMPOUND WITH NOVEL STRUCTUREQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Citrus paradisi (RUTACEAE)
FURO(3,2-G)-(1)-BENZOPYRAN-4-YL)-HEX-4-ENYL]-OXY]-3-7-DIMETHYL-OCT-2-ENYL]-OXY]-7(H)-FURO(3,2-G)-(1)-BENZOPYRAN-7-ONE,4-[[6-HYDROXY-7-[[4-METHYL-1-(1-METHYL-ETHENYL)-6-(7-OXO-7(H):
380736
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
CAROTENE,BETA:
1198018
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
68349
PHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
1083890
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION AND IDENTIFICATION OF
PLASMA EXTENDER
Citrus paradisi (RUTACEAE)
PECTIN(CITRUS PARADISI)
368832
REVIEW OF
Citrus paradisi (RUTACEAE)
346615
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
229580
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
NEOACRIMARINE H
67741
CLINICAL STUDIES
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
368843
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
653387
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
253640
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
625214
PHARMACOLOGY OF EXTRACT - IN VITRO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1141224
PHARMACOLOGY OF EXTRACT - IN VIVO
CORTICOSTERONE-INDUCTION
Citrus paradisi (RUTACEAE)
554281
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Citrus paradisi (RUTACEAE)
69374
CLINICAL STUDIES
METABOLISM INHIBITION
Citrus paradisi (RUTACEAE)
439082
IDENTIFICATION IN BY HPLC
Citrus paradisi (RUTACEAE)
NOBILETINSINENSETINFLAVONE,4'-5-7-8-TETRAMETHOXY:TANGERETINAPIGENIN TRIMETHYL ETHER
715835
PHARMACOLOGY OF EXTRACT - IN HUMANS
CYTOCHROME P450 INDUCTION
Citrus paradisi (RUTACEAE)
NOOTKATONE
1064136
PMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
COUMARIN,7-METHOXY-8-(2-3-EPOXY-ISO-PENTENYL):PSORALEN,5-((6-7-DIHYDROXY-3-7-DIMETHYL-2-OCTENYL)-OXY):
620831
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
67453
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
232631
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPOUND ISOLATED HAS UNUSUAL NAME
Citrus paradisi (RUTACEAE)
CITBISMINE FMARSHARIN
239133
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BENZOPYRAN-7-ONE,4-[[6-HYDROXY-7-[[1-[(1-HYDROXY-1-METHYL)-ETHYL]-4-METHYL-6-(7-OXO-7(H)-FUROL[3-2-G][1]-BENZOPYRAN-4-YL)-4-HEXENYLI-OXY]-3-7-DIMETHYL-2-OCTENYL]-OXY]-7(H)-FUROL[3-2-G]-[1]:
751110
PHARMACOLOGY OF EXTRACT - IN VITRO
ACETYLCHOLINESTERASE INHIBITION
Citrus paradisi (RUTACEAE)
762022
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7'-DIHYDROXY: (R):BERGAMOTTINPARADISIN CPARADISIN BPARADISIN ABERGAMOTTIN-6'-7'-EPOXIDE,(R):
682206
REVIEW OF
Citrus paradisi (RUTACEAE)
617153
BIOSYNTHESISISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NARINGIN
365622
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
646753
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Citrus paradisi (RUTACEAE)
751112
PHARMACOLOGY OF COMPOUND - IN VITRO
ACETYLCHOLINESTERASE INHIBITION
Citrus paradisi (RUTACEAE)
NOOTKATONEAURAPTENE
980301
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NOMILIN
685680
PHARMACOLOGY OF EXTRACT - IN VITRO
REVERSE TRANSCRIPTASE INHIBITION
Citrus paradisi (RUTACEAE)
682878
PHARMACOLOGY OF EXTRACT - IN VIVO
DNA DAMAGE PREVENTION ACTIVITY
Citrus paradisi (RUTACEAE)
601525
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPOXYGENASE INHIBITION
Citrus paradisi (RUTACEAE)
634314
REVIEW OF
Citrus paradisi (RUTACEAE)
1289949
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Citrus paradisi (RUTACEAE)
626234
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7'-DIHYDROXY:
393681
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
178326
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
CITBISMINE B
647113
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
368854
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Citrus paradisi (RUTACEAE)
890599
PHARMACOLOGY OF EXTRACT - IN VIVO
DIURETIC ACTIVITY
Citrus paradisi (RUTACEAE)
625218
PHARMACOLOGY OF EXTRACT - IN VITRO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
330669
GC DATA REPORTEDIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
NOOTKATONECARYOPHYLLENELINALOOL,CIS: OXIDELIMONENEHUMULENEPENTAN-1-OLHEXANOATE,ETHYL: 3-HYDROXY:
393677
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1282828
REVIEW OF
Citrus paradisi (RUTACEAE)
596496
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
371618
MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACOMPLETE SYNTHESIS REPORTEDISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7'-DIHYDROXY:
715831
PHARMACOLOGY OF EXTRACT - IN HUMANS
CYTOCHROME P450 INDUCTION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
589463
IDENTIFICATION IN BY GLCQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
DIPHENYLAMINE
194350
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
CITBISMINE E
276557
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
CITPRESSINE II
390414
PHARMACOLOGY OF EXTRACT - IN VITRO
MUTAGENIC ACTIVITY
Citrus paradisi (RUTACEAE)
68200
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
844580
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
CRYPTOXANTHIN,BETA:CAROTENE,BETA:CAROTENE,ALPHA:
637340
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Citrus paradisi (RUTACEAE)
67744
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
1283873
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
159671
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
CITBISMINE A
68118
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
WEIGHT LOSS
Citrus paradisi (RUTACEAE)
684535
PHARMACOLOGY OF EXTRACT - IN VITRO
MISCELLANEOUS EFFECTS
Citrus paradisi (RUTACEAE)
622143
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
488797
PHARMACOLOGY OF EXTRACT - IN HUMANS
FOOD-DRUG INTERACTION
Citrus paradisi (RUTACEAE)
1096944
IDENTIFICATION IN BY RIAQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
NARINGIN
554505
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
524413
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
647075
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
69627
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
534092
MEDICINAL FOLKLORE REPORTED FOR
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Citrus paradisi (RUTACEAE)
1308605
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6′,7′-DIHYDROXY-DECANAL-ACETAL:
393678
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
379504
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1112886
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Citrus paradisi (RUTACEAE)
368851
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Citrus paradisi (RUTACEAE)
253638
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
FURO(3,2-G)-(1)-BENZOPYRAN-4-YL)-HEX-4-ENYL]-OXY-3-7-DIMETHYL-OCT-2-ENYL]-OXY]-7(H)-FURO(3,2-G)-(1)-BENZOPYRAN-7-ONE,4-[6-HYDROXY-7-[(1-HYDROXY-1-METHYYL)-ETHYL]-4-METHYL-6-(7-OXO-7(H):FURO(3,2-G)-(1)-BENZOPYRAN-4-YL)-HEX-4-ENYL]-OXY]-3-7-DIMETHYL-OCT-2-ENYL]-OXY]-7(H)-FURO(3,2-G)-(1)-BENZOPYRAN-7-ONE,4-[[6-HYDROXY-7-[[4-METHYL-1-(1-METHYL-ETHENYL)-6-(7-OXO-7(H):
483452
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Citrus paradisi (RUTACEAE)
636699
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
UMBELLIFERONE
66708
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
378347
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Citrus paradisi (RUTACEAE)
NARINGIN
653380
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
626231
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
330670
GC DATA REPORTEDIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
NOOTKATONELIMONENEPENTAN-1-OLLINALOOL,CIS: OXIDEHUMULENECARYOPHYLLENEHEXANOATE,ETHYL: 3-HYDROXY:
684541
PHARMACOLOGY OF COMPOUND - IN VITRO
MISCELLANEOUS EFFECTS
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7'-DIHYDROXY:
393680
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
371619
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7'-DIHYDROXY:
715838
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
GF-I-4
380735
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
CAROTENE,ALPHA:
1093562
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
LIMONOL,DEOXY:
450734
IDENTIFICATION IN BY HPLC
Citrus paradisi (RUTACEAE)
ERIOCITRIN,NEO:NARINGIN
547976
PHARMACOLOGY OF EXTRACT - IN HUMANS
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
1198020
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
642181
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
177367
UV SPECTRUM GIVEN FORCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPLETE SYNTHESIS REPORTED
Citrus paradisi (RUTACEAE)
URODIOLENONE
521340
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
647110
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
665567
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
69062
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
BERGAMOTTINNARIRUTINBERGAMOTTIN,6'-7'-DIHYDROXY:NARINGIN
68017
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
68024
PHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
368847
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
1112883
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
515927
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Citrus paradisi (RUTACEAE)
HESPERIDINNARIRUTINHESPERIDIN,NEO:NARINGIN
428940
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
NOMILINIC ACID,DEACETYL: 17-O-BETA-D-GLUCOSIDEOBACUNONE-17-O-BETA-D-GLUCOSIDELIMONIN-17-O-BETA-D-GLUCOSIDENOMILINIC ACID-17-O-BETA-D-GLUCOSIDEICHANGIN-17-O-BETA-D-GLUCOSIDENOMILIN,DEACETYL: 17-O-BETA-D-GLUCOSIDENOMILIN-17-O-BETA-D-GLUCOSIDE
66974
PHARMACOLOGY OF EXTRACT - IN VIVO
LIPID PEROXIDASE INHIBITION
Citrus paradisi (RUTACEAE)
972722
PHARMACOLOGY OF EXTRACT - IN HUMANS
HYPOTENSIVE ACTIVITY
Citrus paradisi (RUTACEAE)
368836
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
395559
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
361023
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
WOUND HEALING ACCELERATION
Citrus paradisi (RUTACEAE)
578461
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
67135
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
368840
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
66822
PHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
401622
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
525143
PHARMACOLOGY OF EXTRACT - IN HUMANS
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
67452
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
370862
PHARMACOLOGY OF EXTRACT - IN HUMANS
PLATELET STIMULANT
Citrus paradisi (RUTACEAE)
179835
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
MARSHDINE
637338
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
968815
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTATHIONE-S-TRANSFERASE INDUCTION
Citrus paradisi (RUTACEAE)
728147
MEDICINAL FOLKLORE REPORTED FOR
ANTIHYPERTENSIVE ACTIVITY
Citrus paradisi (RUTACEAE)
239136
MASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NOOTKATONEBERGAMOTTINCOUMARIN,GERANYL-OXY:
642967
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
276560
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
OSTHENOL
276554
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
GLYCOCITRINE I
522435
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIALLERGENIC ACTIVITY
Citrus paradisi (RUTACEAE)
671599
PHARMACOLOGY OF EXTRACT - IN VIVO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
54766
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Citrus paradisi (RUTACEAE)
NARINGENIN-7-BETA-RUTINOSIDENARINGENIN-7-BETA-NEOHESPERIDOSIDENARINGIN
684546
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
715834
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NOOTKATONE
67704
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1063895
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Citrus paradisi (RUTACEAE)
368835
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
123861
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
NARINGIN-6''-MALONATE
1132972
BIOSYNTHESISQUANTITATIVE DATAISOLATION FROM DURING BIOSYNTHESIS STUDY
Citrus paradisi (RUTACEAE)
NOMILINOATE A-RING LACTONE
53125
IDENTIFICATION IN BY GLCGC DATA REPORTED
Citrus paradisi (RUTACEAE)
CITROSTADIENOLCYCLOEUCALENOLCYCLOARTANOL,24-METHYLENE:CAMPESTEROLLOPHENOL,24-METHYLENE:STIGMASTEROLSITOSTEROL,BETA:CYCLOARTENOL
207879
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
ACRIMARINE G,NEO:
600891
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
239132
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
BENZOPYRAN-7-ONE,4-[[6-HYDROXY-7-[[1-[(1-HYDROXY-1-METHYL)-ETHYL]-4-METHYL-6-(7-OXO-7(H)-FUROL[3-2-G][1]-BENZOPYRAN-4-YL)-4-HEXENYLI-OXY]-3-7-DIMETHYL-2-OCTENYL]-OXY]-7(H)-FUROL[3-2-G]-[1]:
170340
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
CITRACRIDONE I,TRANS-DIHYDROXY:
55584
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
SESELIN
229581
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
NEOACRIMARINE I
68673
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
554510
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Citrus paradisi (RUTACEAE)
253641
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
675559
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
67451
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
675554
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
637337
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
348180
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1245384
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
1064135
PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
PSORALEN,5-(3-7-DIMETHYL-6-EPOXY-2-OCTENYL)-OXY):
636700
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
UMBELLIFERONE
355910
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
728144
PHYTOCHEMICAL SCREENING FORVOUCHER SPECIMEN REPORTED FOR
Citrus paradisi (RUTACEAE)
O
626230
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
637336
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
766344
IDENTIFICATION IN BY HPLC
Citrus paradisi (RUTACEAE)
PONCIRINHESPERIDINNARIRUTINQUERCETINRUTINHESPERIDIN,NEO:DIDYMINNARINGIN
352243
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
789849
REVIEW OF
Citrus paradisi (RUTACEAE)
239134
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
BENZOPYRAN-7-ONE,4-[[6-HYDROXY-7-[[4-METHYL-1-(1-METHYL-ETHENYL)-6-(7-OXO-7(H)-FUROL[3-2-G][1]-BENZOPYRAN-4-YL)-4-HEXENYL]-OXY]-3-7-DIMETHYL-2-OCTENYL]-OXY]-7(H)-FUROL[3-2-G]-[1]
684547
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
BERGAPTEN
368846
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
778305
PHARMACOLOGY OF EXTRACT - IN VITRO
IRON UPTAKE INCREASED
Citrus paradisi (RUTACEAE)
715839
PHARMACOLOGY OF EXTRACT - IN HUMANS
CYTOCHROME P450 INDUCTION
Citrus paradisi (RUTACEAE)
GF-I-4
968817
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTATHIONE-S-TRANSFERASE INDUCTION
Citrus paradisi (RUTACEAE)
778308
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
424498
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
LIMONINNARINGIN
870879
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NARINGIN
625213
PHARMACOLOGY OF EXTRACT - IN VITRO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
715830
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
554508
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
593179
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
646756
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Citrus paradisi (RUTACEAE)
719538
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTATHIONE-S-TRANSFERASE INDUCTION
Citrus paradisi (RUTACEAE)
598610
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1105433
COMPLETE SYNTHESIS REPORTEDIDENTIFICATION IN BY GC/MS
Citrus paradisi (RUTACEAE)
NOOTKATONE B,(+):VETIVONE,ALPHA: 1-10-DIHYDRO:CYPERONE,ALPHA: (+):MENTH-1-ENE-8-THIOL,PARA:CYPERONE,ALPHA: 10-EPI: (-):VETIVONE,ALPHA: (+):NOOTKATONE,BETA-GAMMA: (-):PARADISIOLVETIVONE,ALPHA: 8-9-DIDEHYDRO: (+):NOOTKANONE,8-9-DIDEHYDRO: (+):
103847
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
OBACUNOIC ACID,EPI-ISO: 17-O-BETA-D-GLUCOSIDE
890600
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPERNATREMIA ACTIVITY
Citrus paradisi (RUTACEAE)
368839
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
653379
MASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
276558
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NATSUCITRINE II
389454
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
ASCORBIC ACID
610725
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
67535
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1198021
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
502353
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
66935
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
980299
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Citrus paradisi (RUTACEAE)
LIMONINLIMONATE-A-RING LACTONE
646752
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Citrus paradisi (RUTACEAE)
583570
MEDICINAL FOLKLORE REPORTED FOR
ANTIHYPERTENSIVE ACTIVITY
Citrus paradisi (RUTACEAE)
653381
PHARMACOLOGY OF COMPOUND - IN VITRO
ERYTHROMYCIN N-DEMETHYLASE INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
636695
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
UMBELLIFERONE
890603
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOKALEMIC ACTIVITY
Citrus paradisi (RUTACEAE)
972720
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Citrus paradisi (RUTACEAE)
601524
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLOOXYGENASE INHIBITION
Citrus paradisi (RUTACEAE)
589462
IDENTIFICATION IN BY GLCQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
DIPHENYLAMINE
653384
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
642922
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
625220
PHARMACOLOGY OF COMPOUND - IN VITRO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
NARINGENIN
520804
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
636549
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
602889
QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS
Citrus paradisi (RUTACEAE)
SYNEPHRINE
67726
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
170339
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
FUROPARADINE
534094
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOGLYCEMIC ACTIVITY
Citrus paradisi (RUTACEAE)
684536
PHARMACOLOGY OF EXTRACT - IN VITRO
MISCELLANEOUS EFFECTS
Citrus paradisi (RUTACEAE)
635126
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
647109
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1112884
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
368856
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
675553
MASS-SPECTRAL FRAGMENTATION REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
66973
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTATHIONE PEROXIDASE INHIBITION
Citrus paradisi (RUTACEAE)
353386
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
715837
PHARMACOLOGY OF EXTRACT - IN HUMANS
CYTOCHROME P450 INDUCTION
Citrus paradisi (RUTACEAE)
PARADISIN A
647076
PHARMACOLOGY OF EXTRACT - IN VITRO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
638267
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
767018
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Citrus paradisi (RUTACEAE)
653386
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
483453
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
67090
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
890598
PHARMACOLOGY OF EXTRACT - IN VIVO
URICOSURIC ACTIVITY
Citrus paradisi (RUTACEAE)
1119407
UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
FLAVANONE,5-HYDROXY-4'-METHOXY: 7-O-BETA-D-RHAMNOSYL-GLUCOSIDEFLAVONONE,4'-5-DIHYDROXY: 7-O-BETA-D-RHAMNOSYL-GLUCOSIDE
178327
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus paradisi (RUTACEAE)
CITBISMINE C
622103
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
395805
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
682530
PHARMACOLOGY OF EXTRACT - IN VIVO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1282369
PHARMACOLOGY OF EXTRACT - IN VIVO
HEPATOPROTECTIVE ACTIVITY
Citrus paradisi (RUTACEAE)
67309
CLINICAL STUDIES
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
68550
PHARMACOLOGY OF EXTRACT - IN HUMANS
SEROTONIN (5-HT) UPTAKE INHIBITION
Citrus paradisi (RUTACEAE)
972721
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
964942
IDENTIFICATION IN BY RIAQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
LIMONIN
688606
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
HESPERIDIN,NEO:
68113
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
67395
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1290085
PHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
1308604
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6′,7′-DIHYDROXY-OCTANAL-ACETAL:
69467
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
386111
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
NOOTKATONELINALOOL,CIS: OXIDETERPINEOL,ALPHA:OCIMENE,ALLO:LIMONINLINALOOLDECAN-1-ALTERPINENE,GAMMA:CARYOPHYLLENE,BETA:LINALOOL,TRANS: OXIDECOPAENE,ALPHA:MYRCENEGURJUNENE,BETA:HUMULENE,ALPHA:NARINGIN
1112885
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
636698
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
UMBELLIFERONE
764453
PHARMACOLOGY OF EXTRACT - IN VIVO
ABSORPTION ENHANCEMENT EFFECT
Citrus paradisi (RUTACEAE)
276563
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
CRENULATIN
397678
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIPLATELET ACTIVITY
Citrus paradisi (RUTACEAE)
810911
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLC
Citrus paradisi (RUTACEAE)
LIMONIN
378348
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
372788
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
67586
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
380470
PHARMACOLOGY OF EXTRACT - IN VITRO
LDL OXIDATION INHIBITION
Citrus paradisi (RUTACEAE)
355938
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
239137
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
NOOTKATONEBERGAMOTTINCOUMARIN,GERANYL-OXY:
554509
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
363765
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
NARINGIN
68351
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Citrus paradisi (RUTACEAE)
684540
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7'-DIHYDROXY:
329751
PERFUME PROPERTIES REPORTED FORFLAVOR OR AROMA REPORTED FORREVIEW OF
Citrus paradisi (RUTACEAE)
ESSENTIAL OIL
54875
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NARINGENINAROMADENDRINKAEMPFEROL
368841
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
1113735
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Citrus paradisi (RUTACEAE)
NOMILIN,DEACETYL:LIMONINNOMILINOBACUNONE
806746
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Citrus paradisi (RUTACEAE)
450733
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
HESPERIDIN
642182
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
537315
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIHYPERTENSIVE ACTIVITY
Citrus paradisi (RUTACEAE)
APIGENIN-7-(2-O-ALPHA-RHAMNOSYL-BETA-D-GLUCOSIDE)PRUNIN
368852
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
345805
PHARMACOLOGY OF EXTRACT - IN VITRO
QUINONE REDUCTASE INDUCTION
Citrus paradisi (RUTACEAE)
68016
PHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG INTERACTION
Citrus paradisi (RUTACEAE)
554713
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus paradisi (RUTACEAE)
NARIRUTINNARINGIN
1096947
IDENTIFICATION IN BY RIAQUANTITATIVE DATA
Citrus paradisi (RUTACEAE)
NARINGIN
762020
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
67425
CLINICAL STUDIES
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
948821
PHARMACOLOGY OF EXTRACT - IN VITRO
WBC-MACROPHAGE STIMULANT
Citrus paradisi (RUTACEAE)
66972
PHARMACOLOGY OF EXTRACT - IN VIVO
XANTHINE OXIDASE INHIBITION
Citrus paradisi (RUTACEAE)
253637
MASS-SPECTRAL FRAGMENTATION REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION OF A COMPOUND WITH NOVEL STRUCTUREQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Citrus paradisi (RUTACEAE)
FURO(3,2-G)-(1)-BENZOPYRAN-4-YL)-HEX-4-ENYL]-OXY-3-7-DIMETHYL-OCT-2-ENYL]-OXY]-7(H)-FURO(3,2-G)-(1)-BENZOPYRAN-7-ONE,4-[6-HYDROXY-7-[(1-HYDROXY-1-METHYYL)-ETHYL]-4-METHYL-6-(7-OXO-7(H):
583567
VOUCHER SPECIMEN REPORTED FOR
Citrus paradisi (RUTACEAE)
789922
REVIEW OF
Citrus paradisi (RUTACEAE)
621683
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
684543
PHARMACOLOGY OF COMPOUND - IN VITRO
MISCELLANEOUS EFFECTS
Citrus paradisi (RUTACEAE)
BERGAMOTTIN,6'-7'-DIHYDROXY:
67743
CLINICAL STUDIES
PHARMACOKINETIC STUDY OF
Citrus paradisi (RUTACEAE)
626768
PHARMACOLOGY OF EXTRACT - IN VITRO
MISCELLANEOUS EFFECTS
Citrus paradisi (RUTACEAE)
635101
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
368668
ISOLATION AND IDENTIFICATION OF
Citrus paradisi (RUTACEAE)
NARINGIN
368845
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus paradisi (RUTACEAE)
625217
PHARMACOLOGY OF EXTRACT - IN VITRO
PHARMACOKINETIC ALTERATION
Citrus paradisi (RUTACEAE)
1301307
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
LIPOLYTIC EFFECT
Citrus paradisi (RUTACEAE)